NCT05797220View on ClinicalTrials.gov

The Efficacy of Botulinum Toxin Alone Versus Combined Botulinum Toxin and Topical Diltiazem in Chronic Anal Fissure

CompletedOBSERVATIONAL
Enrollment

217

Participants

Timeline

Start Date

November 4, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

August 30, 2024

Conditions
Anal Fissure Chronic
Interventions
DRUG

Botulinum Toxin Type A Injection [Botox]

DRUG

Botulinum Toxin Type A Injection [Botox] + Diltiazem Hydrochloride 20 Mg/G Rectal Gel

Trial Locations (1)

34196

Istanbul Medipol University, Istanbul

All Listed Sponsors
lead

Istanbul Medipol University Hospital

OTHER

NCT05797220 - The Efficacy of Botulinum Toxin Alone Versus Combined Botulinum Toxin and Topical Diltiazem in Chronic Anal Fissure | Biotech Hunter | Biotech Hunter